Welcome
Oxford Capital Partners is a specialist investment manager, managing growth capital, small buyout capital, special situations and venture capital funds on behalf of institutional and private investors. We focus on the international potential of innovative science and our expertise lies in accelerating businesses with potential for unusual success in high growth in global markets.
Our news
Portfolio news
- TiGenix announces spin-out drug discovery - Arcarios
- Scancell Sign Antibody Licence Agreement with Cancer Research Technology
- Sphere Medical clinical trial proves technology works in hospital patients
- Exosect led consortium awarded grant to bring to market pioneering biotechnology for the control of grain store pests

